BofA lowered the firm’s price target on Morgan Stanley to $90 from $100 and keeps a Buy rating on the shares. Q3 ROTCE of 13.5% was better than the 13% consensus forecast, but “the lack of a clear path” to achieving management’s target without the help of a materially better revenue backdrop “likely contributed” to the stock’s post-earnings selloff given that the stock trades at “a healthy valuation premium to the group,” the analyst tells investors. The Street has underestimated net interest income pressure in the wealth management segment and the combination of continued negative revisions and a premium valuation “finally caught-up with stock,” the analyst argues.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MS:
- Morgan Stanley Stock (NYSE:MS): Chill Out; Capitalize on a Deep Dip
- Fed to propose lowering fees merchants pay when consumers use debit, WSJ says
- Morgan Stanley: M&A to explode when Fed stops rate moves
- Morgan Stanley CEO: ‘Well into’ CEO succession process
- Morgan Stanley CEO sees Fed doing one more rate increase